These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 9428385)
21. The results of radical prostatectomy at a community hospital during the prostate specific antigen era. Smitt MC; Heltzel M Cancer; 1996 Mar; 77(5):928-33. PubMed ID: 8608486 [TBL] [Abstract][Full Text] [Related]
22. Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer. Wheeler TM; Dillioglugil O; Kattan MW; Arakawa A; Soh S; Suyama K; Ohori M; Scardino PT Hum Pathol; 1998 Aug; 29(8):856-62. PubMed ID: 9712429 [TBL] [Abstract][Full Text] [Related]
23. Detection of the 67-kD laminin receptor in prostate cancer biopsies as a predictor of recurrence after radical prostatectomy. Waltregny D; de Leval L; Coppens L; Youssef E; de Leval J; Castronovo V Eur Urol; 2001 Nov; 40(5):495-503. PubMed ID: 11752855 [TBL] [Abstract][Full Text] [Related]
24. Thrombospondin-1 expression in patients with pathologic stage T3 prostate cancer undergoing radical prostatectomy: association with p53 alterations, tumor angiogenesis, and tumor progression. Grossfeld GD; Carroll PR; Lindeman N; Meng M; Groshen S; Feng AC; Hawes D; Cote RJ Urology; 2002 Jan; 59(1):97-102. PubMed ID: 11796289 [TBL] [Abstract][Full Text] [Related]
25. Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers. Noguchi M; Stamey TA; McNeal JE; Yemoto CM J Urol; 2000 Nov; 164(5):1596-600. PubMed ID: 11025712 [TBL] [Abstract][Full Text] [Related]
26. Variation of prostate-specific antigen expression in different tumour growth patterns present in prostatectomy specimens. Gallee MP; Visser-de Jong E; van der Korput JA; van der Kwast TH; ten Kate FJ; Schroeder FH; Trapman J Urol Res; 1990; 18(3):181-7. PubMed ID: 1697709 [TBL] [Abstract][Full Text] [Related]
27. A pathological reassessment of organ-confined, Gleason score 6 prostatic adenocarcinomas that progress after radical prostatectomy. Miyamoto H; Hernandez DJ; Epstein JI Hum Pathol; 2009 Dec; 40(12):1693-8. PubMed ID: 19683331 [TBL] [Abstract][Full Text] [Related]
28. Serum prostate-specific antigen and the biologic progression of prostate cancer. Kabalin JN; McNeal JE; Johnstone IM; Stamey TA Urology; 1995 Jul; 46(1):65-70. PubMed ID: 7541589 [TBL] [Abstract][Full Text] [Related]
29. Elevated levels of peritumoral chondroitin sulfate are predictive of poor prognosis in patients treated by radical prostatectomy for early-stage prostate cancer. Ricciardelli C; Quinn DI; Raymond WA; McCaul K; Sutherland PD; Stricker PD; Grygiel JJ; Sutherland RL; Marshall VR; Tilley WD; Horsfall DJ Cancer Res; 1999 May; 59(10):2324-8. PubMed ID: 10344737 [TBL] [Abstract][Full Text] [Related]
30. Prostate cancer is highly predictable: a prognostic equation based on all morphological variables in radical prostatectomy specimens. Stamey TA; Yemoto CM; McNeal JE; Sigal BM; Johnstone IM J Urol; 2000 Apr; 163(4):1155-60. PubMed ID: 10737486 [TBL] [Abstract][Full Text] [Related]
31. Seminal vesicle involvement after radical prostatectomy: predicting risk factors for progression. Salomon L; Anastasiadis AG; Johnson CW; McKiernan JM; Goluboff ET; Abbou CC; Olsson CA; Benson MC Urology; 2003 Aug; 62(2):304-9. PubMed ID: 12893340 [TBL] [Abstract][Full Text] [Related]
33. Prediction of potentially insignificant prostate cancer in men undergoing radical prostatectomy for clinically organ-confined disease. Miyake H; Sakai I; Harada K; Hara I; Eto H Int J Urol; 2005 Mar; 12(3):270-4. PubMed ID: 15828954 [TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate: prognostic implications. Epstein JI; Eggleston JC Hum Pathol; 1984 Sep; 15(9):853-9. PubMed ID: 6381284 [TBL] [Abstract][Full Text] [Related]
35. Overexpression of Pim-1 during progression of prostatic adenocarcinoma. Cibull TL; Jones TD; Li L; Eble JN; Ann Baldridge L; Malott SR; Luo Y; Cheng L J Clin Pathol; 2006 Mar; 59(3):285-8. PubMed ID: 16505280 [TBL] [Abstract][Full Text] [Related]
36. Expression of prostatic acid phosphatase (PSAP) in transurethral resection specimens of the prostate is predictive of histopathologic tumor stage in subsequent radical prostatectomies. Gunia S; Koch S; May M; Dietel M; Erbersdobler A Virchows Arch; 2009 May; 454(5):573-9. PubMed ID: 19301031 [TBL] [Abstract][Full Text] [Related]
37. The relationship between the extent of surgical margin positivity and prostate specific antigen recurrence in radical prostatectomy specimens. Marks RA; Koch MO; Lopez-Beltran A; Montironi R; Juliar BE; Cheng L Hum Pathol; 2007 Aug; 38(8):1207-11. PubMed ID: 17490720 [TBL] [Abstract][Full Text] [Related]
38. Adenocarcinoma of the prostate with Gleason score 9-10 on core biopsy: correlation with findings at radical prostatectomy and prognosis. Ellis CL; Partin AW; Han M; Epstein JI J Urol; 2013 Dec; 190(6):2068-73. PubMed ID: 23727307 [TBL] [Abstract][Full Text] [Related]
39. Stratification of patient risk based on prostate-specific antigen doubling time after radical retropubic prostatectomy. Tollefson MK; Slezak JM; Leibovich BC; Zincke H; Blute ML Mayo Clin Proc; 2007 Apr; 82(4):422-7. PubMed ID: 17418069 [TBL] [Abstract][Full Text] [Related]
40. Perineural invasion as a predictor of biochemical outcome following radical prostatectomy for select men with clinically localized prostate cancer. D'Amico AV; Wu Y; Chen MH; Nash M; Renshaw AA; Richie JP J Urol; 2001 Jan; 165(1):126-9. PubMed ID: 11125380 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]